DCOY

Gauthier Patricia G.

CIK: 0002148287

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 3, 2026

DCOY Reports Preclinical Data for Once-Weekly Dosing. Decoy Therapeutics released preclinical data supporting a once-weekly intranasal dosing schedule for its DCOY-CoV program. The company is also scheduled to present at The Small Cap Showcase investor conference. These updates provide context for the stock's current trading levels, which sit near significant support.

this person other insiders at DCOY

Transaction History

DCOY▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.